 Orlando, Florida , May 11, 2021 GLOBE NEWSWIRE -- Immune Therapeutics Inc. OTC-PINK: IMUN the Company announced today that FINRA has processed a reverse split of 1-for 1,000 of the issued and outstanding stock. The reverse stock split was completed with the state of Florida on March 12, 2020. FINRAs processing was the last step necessary to fully effectuate the reverse split approved by shareholders in October of 2019. 